BeStock  
Stocks › Biotechnology › RIGL

Rigel Pharmaceuticals RIGL

US equityMarket cap rank #3311Biotechnology
$47.99 +$1.88 (+4.08%)
Pre-market · Oct 8, 8:40 am ET · After hours $47.00 -2.06%
Open$45.64
Prev close$46.11
Day range$45.22 – $48.15
Volume232.6K
Market cap$896.45M
P/E (TTM)2.8
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong uptrend

6 bullish · 1 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average+1.7%BullishTrading above the 20-day average of $47.19
Price vs 50-day average+6.5%BullishTrading above the 50-day average of $45.07
Price vs 200-day average+31.1%BullishTrading above the 200-day average of $36.62
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)55.0BullishMomentum leans positive
MACD (12,26,9)0.61BearishMACD line is below its signal line
Bollinger band position64%BullishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$47.19+1.7%
50-day SMA$45.07+6.5%
200-day SMA$36.62+31.1%

Recent price levels

LevelPrice
20-day high$49.70
20-day low$43.78
60-day high$49.90
60-day low$35.01
Upper Bollinger band$49.96
Lower Bollinger band$44.41

The 50-day average is currently 23.1% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility34.0%
Average true range3.71% of price
Max drawdown (1y)-50.1%
Volume (10d vs 90d)0.69x

Discussion

No comments yet — be the first to weigh in on RIGL.

Leave a comment

Scroll to Top